News articles about MEDIFAST INC (NYSE:MED) have trended somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MEDIFAST INC earned a media sentiment score of 0.05 on Accern’s scale. Accern also gave news articles about the specialty retailer an impact score of 100 out of 100, indicating that recent press coverage is extremely likely to have an effect on the stock’s share price in the near term.

A number of research firms have commented on MED. Sidoti downgraded shares of MEDIFAST INC from a “buy” rating to a “neutral” rating in a research report on Tuesday, May 2nd. Zacks Investment Research upgraded shares of MEDIFAST INC from a “hold” rating to a “buy” rating and set a $48.00 target price on the stock in a report on Friday, March 24th.

MEDIFAST INC (MED) traded up 1.46% on Friday, hitting $40.91. 95,475 shares of the stock traded hands. MEDIFAST INC has a 12-month low of $33.75 and a 12-month high of $47.35. The company’s 50 day moving average price is $42.42 and its 200-day moving average price is $43.11. The stock has a market capitalization of $487.93 million, a P/E ratio of 24.95 and a beta of 0.50.

MEDIFAST INC (NYSE:MED) last posted its earnings results on Thursday, May 4th. The specialty retailer reported $0.51 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.49 by $0.02. MEDIFAST INC had a net margin of 7.23% and a return on equity of 24.94%. The business had revenue of $70.62 million for the quarter, compared to analyst estimates of $72.36 million. During the same quarter in the prior year, the firm earned $0.42 EPS. The firm’s quarterly revenue was down 2.4% compared to the same quarter last year. Analysts predict that MEDIFAST INC will post $2.03 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, August 9th. Stockholders of record on Friday, June 23rd will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 3.13%. The ex-dividend date is Wednesday, June 21st. MEDIFAST INC’s payout ratio is 77.58%.

TRADEMARK VIOLATION WARNING: “Somewhat Favorable Press Coverage Extremely Likely to Impact MEDIFAST INC (NYSE:MED) Stock Price” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/07/16/medifast-inc-med-earning-somewhat-favorable-news-coverage-report-shows-updated-updated-updated.html.

About MEDIFAST INC

Medifast, Inc is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins.

Insider Buying and Selling by Quarter for MEDIFAST INC (NYSE:MED)

Receive News & Stock Ratings for MEDIFAST INC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDIFAST INC and related stocks with our FREE daily email newsletter.